Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Precancerous Conditions × artemisinin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Papillomavirus Infections 3 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Precancerous Conditions 1

Interventions

Peripheral Blood Stem Cell Transplantation 9 Biopsy 9 fludarabine phosphate 8 Cyclophosphamide 8 Whole-Body Irradiation 7 Polymerase Chain Reaction 7 Tacrolimus 6 Mycophenolic Acid 6 Gene Expression Profiling 6 Colposcopy 6 Busulfan 6 Celecoxib 5 Aminolevulinic Acid 5 Sulindac 4 Microarray Analysis 4 Methotrexate 4 Melphalan 4 Immunohistochemistry 4 Epoetin Alfa 4 Cyclosporine 4 Cetuximab 4 Antilymphocyte Serum 4 Vaginal Smears 3 Selenium 3 Imiquimod 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Etoposide 3 Eflornithine 3 Darbepoetin alfa 3 Comparative Genomic Hybridization 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03100045 2021-11-03

ART-AIN

Johns Hopkins University

Phase 1 Completed

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡